Alan Go to Cardiovascular Diseases
This is a "connection" page, showing publications Alan Go has written about Cardiovascular Diseases.
Connection Strength
6.540
-
Triglyceride Levels and Residual Risk of Atherosclerotic Cardiovascular Disease Events and Death in Adults Receiving Statin Therapy for Primary or Secondary Prevention: Insights From the KP REACH Study. J Am Heart Assoc. 2021 10 19; 10(20):e020377.
Score: 0.533
-
Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE). Am Heart J. 2021 05; 235:54-64.
Score: 0.508
-
Contemporary rates and correlates of statin use and adherence in nondiabetic adults with cardiovascular risk factors: The KP CHAMP study. Am Heart J. 2017 Dec; 194:25-38.
Score: 0.400
-
Cardiovascular Disease Consequences of CKD. Semin Nephrol. 2016 07; 36(4):293-304.
Score: 0.370
-
Potential role of differential medication use in explaining excess risk of cardiovascular events and death associated with chronic kidney disease: a cohort study. BMC Nephrol. 2011 Sep 14; 12:44.
Score: 0.265
-
The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research. Circ Cardiovasc Qual Outcomes. 2008 Nov; 1(2):138-47.
Score: 0.217
-
Creating a research data network for cardiovascular disease: the CVRN. Expert Rev Cardiovasc Ther. 2008 Sep; 6(8):1043-5.
Score: 0.215
-
Chronic kidney disease, anemia, and epoetin. N Engl J Med. 2007 Mar 01; 356(9):957; author reply 958-9.
Score: 0.194
-
Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol. 2006 Oct; 17(10):2892-9.
Score: 0.187
-
Epidemiology of non-dialysis-requiring chronic kidney disease and cardiovascular disease. Curr Opin Nephrol Hypertens. 2006 May; 15(3):296-302.
Score: 0.183
-
Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab. 2006 Apr; 91(4):1357-63.
Score: 0.179
-
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004 09 23; 351(13):1296-305.
Score: 0.164
-
Proteomic cardiovascular risk assessment in chronic kidney disease. Eur Heart J. 2023 06 20; 44(23):2095-2110.
Score: 0.150
-
Low concentrations of medium-sized HDL particles predict incident CVD in chronic kidney disease patients. J Lipid Res. 2023 Jun; 64(6):100381.
Score: 0.148
-
Predicting Cardiovascular Events after Sepsis with?Death as a Competing Risk. Ann Am Thorac Soc. 2023 01; 20(1):145-148.
Score: 0.145
-
Performance of the pooled cohort equation in South Asians: insights from a large integrated healthcare delivery system. BMC Cardiovasc Disord. 2022 12 23; 22(1):566.
Score: 0.145
-
Race, Interleukin-6, TMPRSS6 Genotype, and Cardiovascular Disease in Patients With Chronic Kidney Disease. J Am Heart Assoc. 2022 09 20; 11(18):e025627.
Score: 0.142
-
Cardiac Biomarkers and Risk of Atherosclerotic Cardiovascular Disease in Patients with CKD. Kidney360. 2022 05 26; 3(5):859-871.
Score: 0.137
-
Sex Differences in Cardiovascular Outcomes in CKD: Findings From the CRIC Study. Am J Kidney Dis. 2021 08; 78(2):200-209.e1.
Score: 0.129
-
A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and death. Kidney Int. 2021 02; 99(2):456-465.
Score: 0.122
-
Progression of retinopathy and incidence of cardiovascular disease: findings from the Chronic Renal Insufficiency Cohort Study. Br J Ophthalmol. 2021 02; 105(2):246-252.
Score: 0.121
-
Serum Calcification Propensity and Clinical Events in CKD. Clin J Am Soc Nephrol. 2019 11 07; 14(11):1562-1571.
Score: 0.116
-
Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study. Clin J Am Soc Nephrol. 2017 May 08; 12(5):761-771.
Score: 0.097
-
Statins for Primary Prevention in Older Adults: Uncertainty and the Need for More Evidence. JAMA. 2016 Nov 15; 316(19):1971-1972.
Score: 0.095
-
Recent Trends in Cardiovascular Mortality in the United States and Public Health Goals. JAMA Cardiol. 2016 08 01; 1(5):594-9.
Score: 0.093
-
Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies. Am J Kidney Dis. 2016 Oct; 68(4):545-553.
Score: 0.092
-
Electrocardiographic Measures and Prediction of Cardiovascular and Noncardiovascular Death in CKD. J Am Soc Nephrol. 2016 Feb; 27(2):559-69.
Score: 0.086
-
Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2015 Aug; 66(2):266-73.
Score: 0.085
-
Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study. Am J Nephrol. 2014; 40(5):399-407.
Score: 0.083
-
Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2015 Feb; 65(2):267-74.
Score: 0.082
-
Blood pressure and risk of all-cause mortality in advanced chronic kidney disease and hemodialysis: the chronic renal insufficiency cohort study. Hypertension. 2015 Jan; 65(1):93-100.
Score: 0.082
-
Fibroblast growth factor-23 and cardiovascular events in CKD. J Am Soc Nephrol. 2014 Feb; 25(2):349-60.
Score: 0.077
-
Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). BMC Nephrol. 2013 Oct 22; 14:229.
Score: 0.077
-
Sex differences in cardiovascular outcomes in patients with incident hypertension. J Hypertens. 2013 Feb; 31(2):271-7.
Score: 0.073
-
ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA. 2011 Dec 28; 306(24):2673-83.
Score: 0.067
-
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011 Sep 11; 478(7367):103-9.
Score: 0.066
-
Cardiovascular disease among hispanics and non-hispanics in the chronic renal insufficiency cohort (CRIC) study. Clin J Am Soc Nephrol. 2011 Sep; 6(9):2121-31.
Score: 0.066
-
Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Nephrol. 2011; 33(6):477-84.
Score: 0.065
-
Delays in filling clopidogrel prescription after hospital discharge and adverse outcomes after drug-eluting stent implantation: implications for transitions of care. Circ Cardiovasc Qual Outcomes. 2010 May; 3(3):261-6.
Score: 0.060
-
Aortic PWV in chronic kidney disease: a CRIC ancillary study. Am J Hypertens. 2010 Mar; 23(3):282-9.
Score: 0.059
-
Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol. 2009 Aug; 4(8):1302-11.
Score: 0.057
-
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009 May 05; 119(17):2408-16.
Score: 0.056
-
Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation. 2006 Jun 13; 113(23):2713-23.
Score: 0.046
-
Cardiac and Stress Biomarkers and Chronic Kidney Disease Progression: The CRIC Study. Clin Chem. 2019 11; 65(11):1448-1457.
Score: 0.029
-
Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II. Am Heart J. 2019 07; 213:81-90.
Score: 0.028
-
Use of Statins in Adults Older Than 75 Years-Reply. JAMA. 2017 03 14; 317(10):1081.
Score: 0.024
-
Prevalence and Correlates of CKD in Hispanics/Latinos in the United States. Clin J Am Soc Nephrol. 2015 Oct 07; 10(10):1757-66.
Score: 0.022
-
Chronic Renal Insufficiency Cohort Study (CRIC): Overview and Summary of Selected Findings. Clin J Am Soc Nephrol. 2015 Nov 06; 10(11):2073-83.
Score: 0.022
-
Age and sex differences in long-term outcomes following implantable cardioverter-defibrillator placement in contemporary clinical practice: findings from the Cardiovascular Research Network. J Am Heart Assoc. 2015 Jun 02; 4(6):e002005.
Score: 0.021
-
Distribution of asymmetric dimethylarginine among 980 healthy, older adults of different ethnicities. Clin Chem. 2010 Jan; 56(1):111-20.
Score: 0.015
-
Vision and creation of the American Heart Association pharmaceutical roundtable outcomes research centers. Circ Cardiovasc Qual Outcomes. 2009 Nov; 2(6):663-70.
Score: 0.015
-
Validation of a new brief physical activity survey among men and women aged 60-69 years. Am J Epidemiol. 2006 Sep 15; 164(6):598-606.
Score: 0.012
-
ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Commitee to Develop Data Standards on Atrial Fibrillation). J Am Coll Cardiol. 2004 Jul 21; 44(2):475-95.
Score: 0.010
-
ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Data Standards on Atrial Fibrillation). Circulation. 2004 Jun 29; 109(25):3223-43.
Score: 0.010